February 8, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soho House & Co Inc. f/k/a Membership Collective Group Inc. (“Soho” or “the Company”) (NYSE: SHCO). Investors who purchased Soho securities are encouraged to obtain additional information and assist the investigation…. read more
February 8, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snap Inc. (“Snap” or “the Company”) (NYSE: SNAP). Investors who purchased Snap securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Snap has violated federal… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Qualys, Inc. (“Qualys” or “the Company”) (NASDAQ: QLYS). Investors who purchased Qualys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Qualys has violated federal… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or “the Company”) (NASDAQ: BCLI). Investors who purchased Brainstorm Cell securities prior to August 15, 2022, and continue to hold to the present, are encouraged… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerence Inc. (“Cerence” or “the Company”) (NASDAQ: CRNC). Investors who purchased Cerence securities prior to November 16, 2020, and continue to hold to the present, are encouraged to obtain additional information… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
February 6, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Calavo Growers, Inc. (“Calavo” or “the Company”) (NASDAQ: CVGW). Investors who purchased Calavo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Calavo has violated… read more
February 6, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Banco Santander, S.A. (“Santander” or “the Company”) (NYSE: SAN). Investors who purchased Santander securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Santander has violated… read more
February 5, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of WNS (Holdings) Limited (“WNS” or “the Company”) (NYSE: WNS). Investors who purchased WNS securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether WNS has violated… read more
February 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hesai Group (“Hesai” or “the Company”) (NASDAQ: HSAI). Investors who purchased Hesai securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Hesai has violated federal… read more
February 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LifeStance Health Group, Inc. (“ LifeStance” or “the Company”) (NASDAQ: LFST). Investors who purchased LifeStance securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether LifeStance… read more
January 31, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against New York Community Bancorp, Inc. (“NYCB” or “the Company”) (NYSE: NYCB) and certain of its officers. Class Definition: This lawsuit seeks to recover damages… read more
January 30, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Adtalem Global Education Inc. (“Adtalem” or “the Company”) (NYSE: ATGE). Investors who purchased Adtalem securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Adtalem has… read more
January 30, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Silicon Laboratories, Inc. (“Silicon Labs” or “the Company”) (NASDAQ: SLAB). Investors who purchased Silicon Labs securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Silicon… read more
January 29, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Hut 8 Corp. (“Hut 8” or “the Company”) (NASDAQ: HUT) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against… read more
January 24, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolution AB (“Evolution” or “the Company”) (OTCMKTS: EVVTY; EVGGF). Investors who purchased Evolution securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Evolution has violated… read more
January 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equity Lifestyle Properties, Inc. (“Equity” or “the Company”) (NYSE: ELS). Investors who purchased Equity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Equity has… read more
January 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Algoma Steel Group Inc. (“Algoma” or “the Company”) (NASDAQ: ASTL). Investors who purchased Algoma securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Algoma has… read more
January 17, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DocGo Inc. (“DocGo” or “the Company”) (NASDAQ: DCGO). Investors who purchased DocGo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DocGo has violated federal… read more
January 17, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allakos Inc. (“Allakos” or “the Company”) (NASDAQ: ALLK). Investors who purchased Allakos securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Allakos has violated federal… read more
January 15, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gatos Silver, Inc. (“Gatos” or “the Company”) (NYSE: GATO). Investors who purchased Gatos securities prior to December 29, 2020, and continue to hold to the present, are encouraged to obtain additional… read more
January 11, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Endeavour Mining PLC (“Endeavour” or “the Company”) (OTC: EDVMF; TSX: EDV). Investors who purchased Endeavour securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Endeavour has… read more
January 10, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spirit Aerosystems Holdings, Inc. (“Spirit” or “the Company”) (NYSE: SPR). Investors who currently hold Spirit securities are encouraged to obtain additional information and assist the investigation. Investigation Details: The investigation concerns… read more
January 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Carlyle Credit Income Fund f/k/a Vertical Capital Income Fund (“the Fund” or “the Company”) (NYSE: CCIF; VCIF). Investors who purchased the Fund securities are encouraged to obtain additional information and assist… read more
January 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MiMedx Group, Inc. (“MiMedx” or “the Company”) (NASDAQ: MDXG). Investors who purchased MiMedx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MiMedx has violated… read more
January 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cummins Inc. (“Cummins” or “the Company”) (NYSE: CMI). Investors who purchased Cummins securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cummins has violated federal… read more
January 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Grand Canyon Education, Inc. (“GCE” or “the Company”) (NASDAQ: LOPE). Investors who purchased GCE securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GCE has… read more
January 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of First Trust DorseyWright DALI 1 ETF (“test23” or “the Company”) (NASDAQ: DALI). Investors who purchased test23 securities prior to December 28, 2023, and continue to hold to the present, are encouraged… read more
January 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Del Taco Restaurants, Inc. (“test20” or “the Company”) (NASDAQ: TACO). Investors who purchased test20 securities prior to December 26, 2023, and continue to hold to the present, are encouraged to obtain… read more
December 28, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytosorbents Corporation (“Cytosorbents” or “the Company”) (NASDAQ: CTSO). Investors who purchased Cytosorbents securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cytosorbents has violated federal… read more